Search results
Found 374 matches for
Professor Doug Altman, founding director of the Centre for Statistics in Medicine at NDORMS has received The BMJ Lifetime Achievement Award 2015 last night.
Connects-UK launches to foster scientific collaborations between EU and UK researchers in a post-Brexit era
Kennedy Main Research
10 April 2024
Connects-UK, a new pan-European network dedicated to advancing scientific collaborations between researchers in the European Union (EU) and the United Kingdom (UK), was officially launched at an event in London yesterday. The network, led by a diaspora of EU researchers working in the UK, seeks to bridge the gap created by Brexit and ensure that collaboration, innovative research, funding, and knowledge exchange continue to thrive in the post-Brexit era.
New study reveals how T cells gain and maintain tolerance to gut bacteria
Inflammation biology Kennedy Main Research
4 April 2024
The immune system in the intestine maintains a careful balance, tolerating our long-term resident (commensal) gut bacteria while defending against invading pathogens. Under certain circumstances, dysregulation of our intestinal immune response to commensal and pathogenic microbes can drive inflammatory disease.
PD-1 gets an “A” for team-work
Kennedy Main
8 March 2024
A new understanding of the PD-1 axis (programmed death cell) could help shape ongoing efforts to improve treatments for cancer and autoimmune diseases.
Professor Irina Udalova appointed to the MRC’s Infections and Immunity Board
Kennedy Main
1 March 2024
The Medical Research Council’s Infections and Immunity Board (IIB) funds research into infectious human disease and disorders of the human immune system.
Oxford-ZEISS Centre of Excellence officially opened
Kennedy Main
23 February 2024
ZEISS is partnering with the University of Oxford bringing ground-breaking microscopy imaging equipment, and analysis tools, to advance the study of global health and disease.
CRUK funding success for Audrey Gérard
Funding Kennedy Main
14 February 2024
Audrey Gérard has received £ 1.5 million in funding from CRUK for a new research project to unravel the coevolving cancer and immune landscape.
Caroline Morrell awarded an MRC Fellowship
Awards Kennedy Main
9 January 2024
A DPhil candidate at NDORMS, Caroline received the MRC Clinical Research Training Fellowship that has enabled her to further her research into head and neck cancer.
Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford
Kennedy Main
30 November 2023
Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.
Tom Hosack awarded an MRC Fellowship
Awards Kennedy Main
28 November 2023
A DPhil candidate at NDORMS, Tom Hosack received the MRC Clinical Research Training Fellowship to further his research into tissue tropism in PD-1 therapy in immune-mediated inflammatory diseases.
New discovery furthers our understanding of how critical immune cells are controlled during an infection
Kennedy Main
21 November 2023
A recent publication from Audrey Gérard’s lab looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.
New research endoscopy service launches today
Inflammation biology Kennedy Main Trials
2 October 2023
The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at NDORMS and across the University of Oxford.
New professors named at NDORMS
Awards Kennedy Main
14 September 2023
Four NDORMS researchers have been honoured in the 2023 Recognition of Distinction Scheme, the University of Oxford’s annual exercise to confer the title of full professor for excellence in research and teaching.
No link found between patient genetics and response to anti-IL17 therapy
Kennedy Main Publication
4 September 2023
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient’s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.
Monkeypox vaccine team wins delivery award
Awards Kennedy Main
14 July 2023
A collaborative team that responded to the monkeypox (Mpox) epidemic by rolling out a vaccination clinic in Oxford has received an award for delivery in the OUH Staff Recognition Awards.
EPSRC fellowship awarded to Huw Colin-York
Kennedy Main
3 July 2023
Huw Colin-York has been awarded a fellowship from the Engineering and Physical Sciences Research Council (EPSRC) to develop synthetic biology tools to understand the immune response.
Newly discovered cells could be responsible for atherosclerosis complications
Kennedy Main
3 July 2023
A new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.
Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma
Kennedy Main
1 June 2023
A team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.
New partnership will accelerate AI-driven immunotherapies
Inflammation biology Kennedy Main
17 May 2023
Absci will apply its generative AI platform to The Kennedy Institute’s immunology biorepository to speed the discovery and development of multiple therapies
Professor Michael Dustin elected to the Royal Society
Awards Kennedy Main
10 May 2023
The Kennedy professor is one of eight researchers from Oxford University who received a prestigious fellowship from the Royal Society in recognition of their work in the fields of science and medicine.
Feasibility study reviews the use of HRT for post-menopausal women with hand osteoarthritis
Kennedy Main OACentre
21 April 2023
A recent study to test the feasibility of running a randomised controlled trial of hormone replacement therapy (HRT) for post-menopausal women with hand osteoarthritis, has produced positive results. The HOPE-e feasibility study paves the way for researchers to design a full trial.